期刊
THERANOSTICS
卷 13, 期 14, 页码 4993-5016出版社
IVYSPRING INT PUBL
DOI: 10.7150/thno.87968
关键词
atherosclerosis; endothelial inflammatory injury; Neu5Ac; ferroptosis
This study reveals that the metabolite Neu5Ac may regulate the progression of atherosclerosis (AS) by affecting endothelial cell (EC) function. The results show that Neu5Ac exacerbates plaque formation and increases lipid levels in plasma, and triggers EC inflammatory injury to promote AS development. Further mechanistic studies demonstrate that Neu5Ac facilitates the binding of SLC3A2 to ubiquitin, leading to the accumulation of lipid peroxidation in ECs. Additionally, mitochondrial dysfunction is also involved in EC injury after Neu5Ac treatment. The study suggests that inhibiting endothelial ferroptosis may be a novel therapeutic strategy for premature AS.
Background: Atherosclerosis (AS) is still the major cause of cardiovascular disease (CVD) as well as stroke. Endothelial metabolic disorder has been found to be activated and then promote endothelial cells (ECs) injury, which is regarded to initiate AS progression. N-acetylneuraminic acid (Neu5Ac), a metabolite produced by hexosamine-sialic acid pathway branching from glucose metabolism, was presented as a notable biomarker of CVD and is positively correlated with ECs function. However, few studies explain whether Neu5Ac regulate AS progression by affecting EC function as well as its involved mechanisms are still unknown.Methods: Here, we mimicked an animal model in ApoE-/- mice which displaying similar plasma Neu5Ac levels with AS model to investigate its effect on AS progression.Results: We found that Neu5Ac exacerbated plaques area and increased lipids in plasma in absence of HFD feeding, and ECs inflammatory injury was supposed as the triggering factor upon Neu5Ac treatment with increasing expression of IL-1 beta, ICAM-1, and promoting ability of monocyte adhesion to ECs. Mechanistic studies showed that Neu5Ac facilitated SLC3A2 binding to ubiquitin and then triggered P62 mediated degradation, further leading to accumulation of lipid peroxidation in ECs. Fer-1 could inhibit ECs injury and reverse AS progression induced by Neu5Ac in ApoE-/- mice. Interestingly, mitochondrial dysfunction was also partly participated in ECs injury after Neu5Ac treatment and been reversed by Fer-1.Conclusions: Together, our study unveils a new mechanism by which evaluated metabolite Neu5Ac could promote SLC3A2 associated endothelial ferroptosis to activate ECs injury and AS plaque progression, thus providing a new insight into the role of Neu5Ac-ferroptosis pathway in AS. Also, our research revealed that pharmacological inhibition of ferroptosis may provide a novel therapeutic strategy for premature AS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据